Brian Kirby

31PUBLICATIONS
80CO-AUTHORS
Major global burdens of diseaseCardiology (incl. cardiovascular diseases)Gene and molecular therapyInnate immunityAerospace engineering not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 15, 2026
A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

|Nov 22, 2025
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals.

Raymond Matthews, April W Armstrong, Matthias Augustin

|May 17, 2025
Hidradenitis suppurativa and mortality in Ireland over a 10-year period: an assessment of statistics and review of the literature.

Emily K Pender, Rosalind Hughes, Brian Kirby

|Aug 14, 2024
Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease.

Niamh Kearney, Xin Chen, Yingtao Bi

|Aug 01, 2024
GRAPPA Point-Counterpoint: Should Biologics Be Used for Mild Psoriasis?

Gretchen D Ball, Hassan Hamade, Alice B Gottlieb

|Feb 02, 2024
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.

Hans Christian Ring, Jonathan Thorsen, Brian Kirby

Pageof 6

Frequent Collaborators

10 joint publications

Niamh Kearney

7 joint publications

Roisin Hambly

6 joint publications

Jean M Fletcher

3 joint publications

Emily Pender